Detalhe da pesquisa
1.
Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise.
Hepatol Res
; 49(6): 637-652, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811073
2.
PTEN Down-Regulation Promotes ß-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.
Hepatology
; 66(3): 908-921, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437835
3.
Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis.
J Hepatol
; 62(6): 1296-303, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623824
4.
Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma.
Nanomedicine
; 11(1): 67-76, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25101883
5.
Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.
Clin Sci (Lond)
; 126(11): 775-84, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24283268
6.
Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
Clin Sci (Lond)
; 126(3): 243-52, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23822114
7.
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
J Hepatol
; 57(3): 592-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22634341
8.
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).
J Thorac Oncol
; 16(2): 278-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188912
9.
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.
Clin Sci (Lond)
; 118(6): 401-10, 2009 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19832698
10.
Targeting vessels to treat hepatocellular carcinoma.
Clin Sci (Lond)
; 114(7): 467-77, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18302534
11.
Rapamycin impacts positively on longevity, despite glucose intolerance induction.
J Hepatol
; 57(6): 1368-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22796895
12.
Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.
J Drug Target
; 15(9): 623-31, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17968716
13.
PI(3)K/PTEN/AKT pathway.
J Hepatol
; 54(6): 1317-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21168457
14.
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.
Genes Cancer
; 6(7-8): 317-327, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26413215
15.
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Nat Commun
; 5: 4309, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24978903
16.
Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis.
Eur J Pharmacol
; 705(1-3): 86-95, 2013 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23454556
17.
Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma.
Mol Cancer Ther
; 10(6): 1007-17, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21487053
18.
Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma.
J Hepatol
; 49(1): 78-87, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18486258
19.
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.
J Hepatol
; 46(5): 840-8, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17321636
20.
Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.
Gastroenterology
; 130(7): 2179-88, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16762638